ALK and non-small cell lung carcinoma: Although many previous studies have reported other ALK fusion partners and breakpoints, little is still known about the true oncogenic role of fusion variants other than the common fusions found in NSCLC,32 let alone the clinical efficacy of ALK-TKIs for rare ALK fusion variants.